IBDEI1Z1 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,31481,0)
;;=O36.8123^^126^1626^22
;;^UTILITY(U,$J,358.3,31481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31481,1,3,0)
;;=3^Decreased fetal movements, second trimester, fetus 3
;;^UTILITY(U,$J,358.3,31481,1,4,0)
;;=4^O36.8123
;;^UTILITY(U,$J,358.3,31481,2)
;;=^5017092
;;^UTILITY(U,$J,358.3,31482,0)
;;=O36.8133^^126^1626^28
;;^UTILITY(U,$J,358.3,31482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31482,1,3,0)
;;=3^Decreased fetal movements, third trimester, fetus 3
;;^UTILITY(U,$J,358.3,31482,1,4,0)
;;=4^O36.8133
;;^UTILITY(U,$J,358.3,31482,2)
;;=^5017099
;;^UTILITY(U,$J,358.3,31483,0)
;;=O36.8124^^126^1626^23
;;^UTILITY(U,$J,358.3,31483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31483,1,3,0)
;;=3^Decreased fetal movements, second trimester, fetus 4
;;^UTILITY(U,$J,358.3,31483,1,4,0)
;;=4^O36.8124
;;^UTILITY(U,$J,358.3,31483,2)
;;=^5017093
;;^UTILITY(U,$J,358.3,31484,0)
;;=O36.8134^^126^1626^29
;;^UTILITY(U,$J,358.3,31484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31484,1,3,0)
;;=3^Decreased fetal movements, third trimester, fetus 4
;;^UTILITY(U,$J,358.3,31484,1,4,0)
;;=4^O36.8134
;;^UTILITY(U,$J,358.3,31484,2)
;;=^5017100
;;^UTILITY(U,$J,358.3,31485,0)
;;=O36.8125^^126^1626^24
;;^UTILITY(U,$J,358.3,31485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31485,1,3,0)
;;=3^Decreased fetal movements, second trimester, fetus 5
;;^UTILITY(U,$J,358.3,31485,1,4,0)
;;=4^O36.8125
;;^UTILITY(U,$J,358.3,31485,2)
;;=^5017094
;;^UTILITY(U,$J,358.3,31486,0)
;;=O36.8135^^126^1626^30
;;^UTILITY(U,$J,358.3,31486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31486,1,3,0)
;;=3^Decreased fetal movements, third trimester, fetus 5
;;^UTILITY(U,$J,358.3,31486,1,4,0)
;;=4^O36.8135
;;^UTILITY(U,$J,358.3,31486,2)
;;=^5017101
;;^UTILITY(U,$J,358.3,31487,0)
;;=O43.011^^126^1626^32
;;^UTILITY(U,$J,358.3,31487,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31487,1,3,0)
;;=3^Fetomaternal placental transfusion syndrome, first trimester
;;^UTILITY(U,$J,358.3,31487,1,4,0)
;;=4^O43.011
;;^UTILITY(U,$J,358.3,31487,2)
;;=^5017389
;;^UTILITY(U,$J,358.3,31488,0)
;;=O43.012^^126^1626^31
;;^UTILITY(U,$J,358.3,31488,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31488,1,3,0)
;;=3^Fetomaternal placental transfuse syndrome, second trimester
;;^UTILITY(U,$J,358.3,31488,1,4,0)
;;=4^O43.012
;;^UTILITY(U,$J,358.3,31488,2)
;;=^5017390
;;^UTILITY(U,$J,358.3,31489,0)
;;=O43.013^^126^1626^33
;;^UTILITY(U,$J,358.3,31489,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31489,1,3,0)
;;=3^Fetomaternal placental transfusion syndrome, third trimester
;;^UTILITY(U,$J,358.3,31489,1,4,0)
;;=4^O43.013
;;^UTILITY(U,$J,358.3,31489,2)
;;=^5017391
;;^UTILITY(U,$J,358.3,31490,0)
;;=O36.0110^^126^1626^55
;;^UTILITY(U,$J,358.3,31490,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31490,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,unsp fts
;;^UTILITY(U,$J,358.3,31490,1,4,0)
;;=4^O36.0110
;;^UTILITY(U,$J,358.3,31490,2)
;;=^5016842
;;^UTILITY(U,$J,358.3,31491,0)
;;=O36.0111^^126^1626^56
;;^UTILITY(U,$J,358.3,31491,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,31491,1,3,0)
;;=3^Maternal care for Anti-D antibodies,1st tri,fts 1
;;^UTILITY(U,$J,358.3,31491,1,4,0)
;;=4^O36.0111
;;^UTILITY(U,$J,358.3,31491,2)
;;=^5016843
;;^UTILITY(U,$J,358.3,31492,0)
;;=O36.0112^^126^1626^57
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1Z1 3748 printed Dec 13, 2024@02:18:34 Page 2
IBDEI1Z1 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,31481,0)
+2 ;;=O36.8123^^126^1626^22
+3 ;;^UTILITY(U,$J,358.3,31481,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,31481,1,3,0)
+6 ;;=3^Decreased fetal movements, second trimester, fetus 3
+7 ;;^UTILITY(U,$J,358.3,31481,1,4,0)
+8 ;;=4^O36.8123
+9 ;;^UTILITY(U,$J,358.3,31481,2)
+10 ;;=^5017092
+11 ;;^UTILITY(U,$J,358.3,31482,0)
+12 ;;=O36.8133^^126^1626^28
+13 ;;^UTILITY(U,$J,358.3,31482,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,31482,1,3,0)
+16 ;;=3^Decreased fetal movements, third trimester, fetus 3
+17 ;;^UTILITY(U,$J,358.3,31482,1,4,0)
+18 ;;=4^O36.8133
+19 ;;^UTILITY(U,$J,358.3,31482,2)
+20 ;;=^5017099
+21 ;;^UTILITY(U,$J,358.3,31483,0)
+22 ;;=O36.8124^^126^1626^23
+23 ;;^UTILITY(U,$J,358.3,31483,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,31483,1,3,0)
+26 ;;=3^Decreased fetal movements, second trimester, fetus 4
+27 ;;^UTILITY(U,$J,358.3,31483,1,4,0)
+28 ;;=4^O36.8124
+29 ;;^UTILITY(U,$J,358.3,31483,2)
+30 ;;=^5017093
+31 ;;^UTILITY(U,$J,358.3,31484,0)
+32 ;;=O36.8134^^126^1626^29
+33 ;;^UTILITY(U,$J,358.3,31484,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,31484,1,3,0)
+36 ;;=3^Decreased fetal movements, third trimester, fetus 4
+37 ;;^UTILITY(U,$J,358.3,31484,1,4,0)
+38 ;;=4^O36.8134
+39 ;;^UTILITY(U,$J,358.3,31484,2)
+40 ;;=^5017100
+41 ;;^UTILITY(U,$J,358.3,31485,0)
+42 ;;=O36.8125^^126^1626^24
+43 ;;^UTILITY(U,$J,358.3,31485,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,31485,1,3,0)
+46 ;;=3^Decreased fetal movements, second trimester, fetus 5
+47 ;;^UTILITY(U,$J,358.3,31485,1,4,0)
+48 ;;=4^O36.8125
+49 ;;^UTILITY(U,$J,358.3,31485,2)
+50 ;;=^5017094
+51 ;;^UTILITY(U,$J,358.3,31486,0)
+52 ;;=O36.8135^^126^1626^30
+53 ;;^UTILITY(U,$J,358.3,31486,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,31486,1,3,0)
+56 ;;=3^Decreased fetal movements, third trimester, fetus 5
+57 ;;^UTILITY(U,$J,358.3,31486,1,4,0)
+58 ;;=4^O36.8135
+59 ;;^UTILITY(U,$J,358.3,31486,2)
+60 ;;=^5017101
+61 ;;^UTILITY(U,$J,358.3,31487,0)
+62 ;;=O43.011^^126^1626^32
+63 ;;^UTILITY(U,$J,358.3,31487,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,31487,1,3,0)
+66 ;;=3^Fetomaternal placental transfusion syndrome, first trimester
+67 ;;^UTILITY(U,$J,358.3,31487,1,4,0)
+68 ;;=4^O43.011
+69 ;;^UTILITY(U,$J,358.3,31487,2)
+70 ;;=^5017389
+71 ;;^UTILITY(U,$J,358.3,31488,0)
+72 ;;=O43.012^^126^1626^31
+73 ;;^UTILITY(U,$J,358.3,31488,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,31488,1,3,0)
+76 ;;=3^Fetomaternal placental transfuse syndrome, second trimester
+77 ;;^UTILITY(U,$J,358.3,31488,1,4,0)
+78 ;;=4^O43.012
+79 ;;^UTILITY(U,$J,358.3,31488,2)
+80 ;;=^5017390
+81 ;;^UTILITY(U,$J,358.3,31489,0)
+82 ;;=O43.013^^126^1626^33
+83 ;;^UTILITY(U,$J,358.3,31489,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,31489,1,3,0)
+86 ;;=3^Fetomaternal placental transfusion syndrome, third trimester
+87 ;;^UTILITY(U,$J,358.3,31489,1,4,0)
+88 ;;=4^O43.013
+89 ;;^UTILITY(U,$J,358.3,31489,2)
+90 ;;=^5017391
+91 ;;^UTILITY(U,$J,358.3,31490,0)
+92 ;;=O36.0110^^126^1626^55
+93 ;;^UTILITY(U,$J,358.3,31490,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,31490,1,3,0)
+96 ;;=3^Maternal care for Anti-D antibodies,1st tri,unsp fts
+97 ;;^UTILITY(U,$J,358.3,31490,1,4,0)
+98 ;;=4^O36.0110
+99 ;;^UTILITY(U,$J,358.3,31490,2)
+100 ;;=^5016842
+101 ;;^UTILITY(U,$J,358.3,31491,0)
+102 ;;=O36.0111^^126^1626^56
+103 ;;^UTILITY(U,$J,358.3,31491,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,31491,1,3,0)
+106 ;;=3^Maternal care for Anti-D antibodies,1st tri,fts 1
+107 ;;^UTILITY(U,$J,358.3,31491,1,4,0)
+108 ;;=4^O36.0111
+109 ;;^UTILITY(U,$J,358.3,31491,2)
+110 ;;=^5016843
+111 ;;^UTILITY(U,$J,358.3,31492,0)
+112 ;;=O36.0112^^126^1626^57
